100 Mg Bosutinib Tablets

Name: 100 Mg Bosutinib Tablets
Brand: NEETCO BIOPHARMA
Price: 5000 INR
Availability: InStock

Price 5000 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

100 Mg Bosutinib Tablets Specification

Indication
Treatment of chronic myeloid leukemia (CML)

Salt Composition
Bosutinib 100 mg

Dosage Form
Film-coated Tablet

Feature
Prescription medicine for targeted cancer therapy

Ingredients
Bosutinib monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol

Application
Oncology

Physical Color/Texture
Light yellow, round, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

About 100 Mg Bosutinib Tablets

Introducing the new release of Bosutris 100 Mg Bosutinib Tablets, a premier, in-demand prescription medicine for targeted cancer therapy. Each spectacular bottle contains 30 light yellow, round, film-coated tablets for oral administration, designed specifically for the treatment of chronic myeloid leukemia (CML). Approved by both the US FDA and EMA, Bosutris delivers phenomenal efficacy with a shelf life of 24 months. Jump on this trusted solution distributed and supplied across India, meeting strict pharmaceutical standards. Please note: contraindicated in patients with hypersensitivity to Bosutinib or any ingredient. Store below 30C, away from moisture and light.

Advanced Features and Other Applications

Bosutris 100 Mg Tablets excel in oncology applications, providing targeted therapy for CML. The formulation boasts features such as film-coated tablets for ease of administration and precision dosing. Its machine-packed bottles assure tamper-resistant packaging and consistent tablet quality. Bosutris is highly versatile for hospital, clinical, and export channels, assuring reliability in various healthcare settings. Odorless and designed for optimal patient convenience, it is a standout pharmaceutical product.

Certifications, Samples, and Shipping Information

Bosutris 100 Mg Tablets are certified by US FDA and EMA, demonstrating stringent quality control. Distributors and suppliers may request samples to assess product performance before full expenditure. The tablets are available for export from India with competitive FOB port rates and minimal additional charge. Each transaction is backed by the assurance of proper handling and regulatory compliance, making Bosutris a cost-effective and dependable choice in oncology medicine.

FAQ's of 100 Mg Bosutinib Tablets:

Q: How should Bosutris 100 Mg Bosutinib Tablets be administered?

A: Bosutris 100 Mg Tablets are intended to be taken orally, as prescribed by your healthcare provider. Follow the dosage and schedule recommended by your physician for effective results.

Q: What is the primary indication for Bosutinib 100 Mg Tablets?

A: These premier tablets are specifically indicated for the treatment of chronic myeloid leukemia (CML), offering targeted cancer therapy as approved by leading regulatory agencies.

Q: When is Bosutris contraindicated?

A: Bosutris should not be taken by individuals with hypersensitivity to Bosutinib or any tablet excipients. Always consult your doctor to assess suitability before use.

Q: Where can I obtain samples of Bosutris 100 Mg Tablets for evaluation?

A: Samples can be requested from authorized distributors, exporters, or suppliers in India, following local regulations and company sample policy.

Q: What common side effects should patients be aware of with Bosutinib?

A: The most frequently reported side effects include nausea, diarrhea, abdominal pain, rash, and increased liver enzymes. Notify your healthcare provider if you experience any adverse effects.

Q: How are Bosutris Tablets stored and handled during shipping?

A: Bosutris Tablets must be stored below 30C, protected from moisture and light. During shipping, certified practices ensure the product maintains its integrity and efficacy.

Tell us about your requirement